Patents by Inventor Taihua WANG

Taihua WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12211264
    Abstract: An optical satellite remote sensing transfer calibration method based on near-space aerostat, including: performing a temporal-spatial matching between first observation image data of a target region collected by a benchmark radiometric payload and second observation image data of the target region collected by a satellite-borne payload, to obtain a plurality of matchups of observation image data (S1); obtaining an average radiance of the benchmark radiometric payload from a plurality of first observation image data (S2); obtaining an average DN captured by the satellite payload in the target region from a plurality of second observation image data (S3); obtaining a matching radiance for an observation band of the benchmark radiometric payload corresponding to the satellite payload based on the average radiance of the benchmark radiometric payload (S4); and obtaining a calibration coefficient of the satellite payload based on the matching radiance and the average DN (S5).
    Type: Grant
    Filed: April 22, 2022
    Date of Patent: January 28, 2025
    Assignee: Aerospace Information Research Institute, Chinese Academy of Sciences
    Inventors: Lingling Ma, Ning Wang, Geer Teng, Qiang Liu, Yongguang Zhao, Jingmei Li, Taihua Zhang, Yanchu Yang, Yaokai Liu, Caixia Gao, Wan Li, Lu Ren, Guangzhou Ouyang, Yifang Niu
  • Patent number: 11761002
    Abstract: An application of a transgenic stem cell-derived exosome in preparing a medicament or whitening cosmetic is provided. In the present disclosure, miR-27b-3p is transfected into an epidermal stem cell, and a transgenic stem cell-derived exosome is harvested. It is experimentally verified that the exosome can inhibit the expression of PIK3R3 protein in melanocytes and the proliferation and migration of melanocytes; and safety experiments further demonstrate the safety of the exosome. Therefore, corresponding medicaments or cosmetics prepared from the exosome have excellent medicinal and cosmetic application prospects.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: September 19, 2023
    Assignee: GUANGDONG CELL BIOTECHNOLOGY CO., LTD.
    Inventors: Xinyi Shi, Taihua Wang, Fei Peng, Jing Li
  • Publication number: 20230193270
    Abstract: An application of a transgenic stem cell-derived exosome in preparing a medicament or whitening cosmetic is provided. In the present disclosure, miR-27b-3p is transfected into an epidermal stem cell, and a transgenic stem cell-derived exosome is harvested. It is experimentally verified that the exosome can inhibit the expression of PIK3R3 protein in melanocytes and the proliferation and migration of melanocytes; and safety experiments further demonstrate the safety of the exosome. Therefore, corresponding medicaments or cosmetics prepared from the exosome have excellent medicinal and cosmetic application prospects.
    Type: Application
    Filed: March 22, 2021
    Publication date: June 22, 2023
    Applicant: GUANGDONG CELL BIOTECHNOLOGY CO., LTD.
    Inventors: Xinyi SHI, Taihua WANG, Fei PENG, Jing LI